R
10.45
0.40 (3.98%)
| Penutupan Terdahulu | 10.05 |
| Buka | 9.90 |
| Jumlah Dagangan | 391,451 |
| Purata Dagangan (3B) | 238,506 |
| Modal Pasaran | 5,181,991,936 |
| Harga / Buku (P/B) | 2.43 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Oct 2026 |
| EPS Cair (TTM) | -0.010 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.04% |
| Nisbah Semasa (MRQ) | 41.92 |
| Aliran Tunai Operasi (OCF TTM) | -4.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.88 M |
| Pulangan Atas Aset (ROA TTM) | -28.11% |
| Pulangan Atas Ekuiti (ROE TTM) | -43.18% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Regencell Bioscience Holdings L | - | - |
AISkor Stockmoo
1.6
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | 1.63 |
|
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people’s immune systems. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 93.84% |
| % Dimiliki oleh Institusi | 0.07% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Fox Run Management, L.L.C. | 30 Jun 2026 | 20,691 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
AI Analisis Teknikal
Buka tab Teknikal untuk menjana analisis terkini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |